BSD Medical enters Japanese market with new cancer treatment

By Lisa Kerner

Erie, Pa., Jan. 4 - BSD Medical Corp. has entered into a distribution agreement with Ktech Corp. to sell BSD Medical's cancer treatment systems in Japan, the world's second largest medical market.

This agreement concludes a lengthy search and negotiation process as part of BSD Medical's global strategy to establish a chain of distributors in the Pacific Rim, the company said.

Ktech has more than 30 years of experience in importing and distributing high-tech medical capital equipment in Japan, with a primary focus on the introduction of state-of-the-art medical technology. Ktech's services include sales and marketing, sales engineering support, field service and product support.

"We believe that Ktech is highly qualified to sell and support our cancer therapy systems in Japan, and are very enthusiastic about our new relationship," Hyrum A. Mead, president and chief executive officer of BSD Medical, said in a news release.

BSD Medical, already working with an established distributor in China, has obtained regulatory approval for the sale of its BSD-2000 in China. BSD Medical's objective is to pursue a similar marketing strategy in Japan. Japan and China together represent a major percentage of the total Pacific Rim market.

Salt Lake City-based BSD Medical produces systems that deliver precision-focused RF/microwave energy to treat cancer and boost the effectiveness of companion radiation and/or chemotherapy treatments.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.